• Olink interviewed in a Science technology feature on neurological biomarkers

    Olink Proteomics CEO & President, Jon Heimer, was recently interviewed for a Science/AAAS technology feature called “Biomarkers on the brain”.  In this article, the role of developing new technologies in identifying new biomarkers to improve our understanding and treatment of neurological diseases.

    You can read the article by visiting the Science/AAAS  website here.